Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06878859 · ClinicalTrials.gov registry record · NA
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
A NA study of Cannabis Use Disorder and Mental Disorder, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06878859 is a NA study of Cannabis Use Disorder and Mental Disorder that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 107-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06878859, a NA study of Cannabis Use Disorder and Mental Disorder, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the feasibility, acceptability, and preliminary efficacy of a digital intervention for co-occurring cannabis use and depression. Participants will be randomized to complete Amplification of Positivity - Cannabis Use (AMP-C) or symptom tracking. The main outcomes will include changes in depressive symptoms and cannabis use, as well as usability ratings.
Conditions Studied
Interventions
- BEHAVIORAL Amplification of Positivity - Cannabis Use (AMP-C)
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-02 |
| Est. Completion | 2029-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06878859
The ClinicalTrials.gov registry entry for NCT06878859 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 107-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (25% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cannabis Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Amplification of Positivity - Cannabis Use (AMP-C) is the first listed.
NCT06878859 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06878859 about?
NCT06878859 is a clinical study titled "Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use". The purpose of this study is to examine the feasibility, acceptability, and preliminary efficacy of a digital intervention for co-occurring cannabis use and depression. Participants will be randomized to complete Amplification of Positivity - Cannabis Use (AMP-C) or symptom tracking. The main outcom...
What is the current status of trial NCT06878859?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-02. Estimated completion is 2029-01.
What conditions does trial NCT06878859 study?
This clinical trial studies the following conditions: Cannabis Use Disorder, Mental Disorder, Depression - Major Depressive Disorder.
What interventions are being tested in trial NCT06878859?
The interventions under investigation include: Amplification of Positivity - Cannabis Use (AMP-C) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06878859?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06878859 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
Evaluation of a Brief Computerized and Smart Phone-based Intervention for Stress in Regular Cannabis Users
RECRUITING · NA
-
Determining the Effect of Six Weeks of Cannabis Abstinence on Fronto- Striatal fMRI Markers in Adolescents With Cannabis Use Disorder (ABSCAN)
RECRUITING · NA
-
The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV
RECRUITING · NA
-
A Brief Intervention for Cannabis Use
RECRUITING · NA
-
RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.